Qu'est-ce que la goutte ?
1. Saag KG et Mikuls TR. Recent advances in the epidemiology of gout. Curr Rheumatol Rep 2005;7:235-41.
2. Bardin T. Epidémiologie de la goutte. Revue du rhumatisme 2007;74:147-9.
3. Zhang W et al. EULAR evidence based recommendations for gout. Part I: diagnosis. Report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT). Ann Rheum Dis 2006:65:1301-11.
Explications sur la maladie
1. Falasca GF. Metabolic diseases: gout. Clinics in Dermatology 2006;24:498-508.
2. Bardin T et al. Goutte. In : Godeau P, Hersin S, Piette JC, editors. Traité de Médecine ; 4e édition, Paris ; Médecine Sciences Flammarion, 2004, 2261-71.
3. Lioté F, Ea H-K. physiopathologie de l’inflammation microcristalline. Rev Rhum 2007.
Manifestations de la goutte
1. Punzi et Oliviero F. Diagnostic clinique des arthropathies microcristallines. Revue du Rhumatisme 2007:74:138-46.
2. Lioté F et Ea HK. Physiopathogénie de l’inflammation microcristalline. Revue du Rhumatisme 2007;74:1-7.
3. Bardin T et al. Goutte. In : Godeau P, Hersin S, Piette JC, editors. Traité de Médecine ; 4e édition, Paris ; Médecine Sciences Flammarion, 2004, 2261-71
Causes et facteurs déclenchants
1. Bardin T et al. Goutte. In: Godeau P, Hersin S, Piette JC, editors. Traité de Médecine ; 4e édition, Paris ; Médecine Sciences Flammarion, 2004, 2261-71.
2. Bardin T. Epidémiologie de la goutte. Revue du rhumatisme 2007;74:147-9.
3. Zhang W et al. EULAR evidence based recommendations for gout. Part I: diagnosis. Report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT). Ann Rheum Dis 2006:65:1301-11.
4. Saag KG et Mikuls TR. Recent advances in the epidemiology of gout. Curr Rheumatol Rep 2005;7:235-41.
5. Punzi et Oliviero F. Diagnostic pratique des arthropathies microcristallines. Revue du Rhumatisme 2007:74:138-46.
6. Choi HK, Curhan G. Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. BMJ 2008;336:309-12.
7. Choi HK, et al. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med. 2004;350:1093-103.
8. Gao X, et al. Vitamin C intake and serum uric acid concentration in men. J Rheumatol 2008;35:1853-8.
9. Huang HY, et al. The effects of vitamin C supplementation on serum concentrations of uric acid: results of a randomized controlled trial. Arthritis Rheum 2005;52:1843-7.
10. Jacob J, et al. Consumption of cherries lowers plasma urate in healthy women.J Nutr 2003;133:1826-9.
11. Kiyohara C, et al. Inverse association between coffee drinking and serum uric acid concentrations in middle-aged Japanese males. Br J Nutr 1999;82:125-30. ;
12. Choi HK, Curhan G. Coffee, tea, and caffeine consumption and serum uric acid level: the third national health and nutrition examination survey. Arthritis Rheum 2007;57:816-21.
13. Williams PT. Effects of diet, physical activity and performance, and body weight on incident gout in ostensibly healthy, vigorously active men. Am J Clin Nutr 2008;87:1480-7.
Comprendre les crises de goutte
1. Choi HK et al. Pathogenesis of gout. Ann Intern Med 2005:143:499-516.
2. Lioté F et Ea HK. Physiopathogénie de l’inflammation microcristalline. Revue du Rhumatisme 2007;74:131-7.
3. Lioté F et Ea HK. Recent developments in crystal-induced inflammation pathogenesis and management. Current Rheumatology Reports 2007;9:243-50.
Comprendre la goutte chronique
1. Choi HK et al. Pathogenesis of gout. Ann Intern Med 2005:143:499-516.
2. Bardin T et al. Goutte. In: Godeau P, Hersin S, Piette JC, editors. Traité de Médecine ; 4e édition, Paris ; Médecine Sciences Flammarion, 2004, 2261-71.
3. Lioté F et Ea HK. Physiopathogénie de l’inflammation microcristalline. Revue du Rhumatisme 2007;74:131-7.
Diagnostiquer et traiter la goutte
1. Zhang W et al. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006:65:1312-24.
Diagnostiquer
1. Zhang W et al. EULAR evidence based recommendations for gout. Part II : Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006:65:1312-24.
2. Punzi et Oliviero F. Diagnostic clinique des arthropathies microcristallines. Revue du Rhumatisme 2007:74:138-46.
Traitement de la crise
1. Zhang W et al. EULAR evidence based recommendations for gout. Part II : Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006:65:1312-24.
2. Lioté F et Bardin T. Traitement de la goutte. Revue du Rhumatisme 2007;74:160-7.
Traitement de la goutte chronique (Traitement de fond)
1. Zhang W et al. EULAR evidence based recommendations for gout. Part II : Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006:65:1312-24.
2. Lioté F et Bardin T. Traitement de la goutte. Revue du Rhumatisme 2007;74:160-7.
